Oslo, 21 January 2010 - Attached is an updated investor presentation of PCI
Biotech. The presentation will be used in meetings with potential investors in
London today, 21(st) January 2010.
Contact information:
PCI Biotech Holding ASA, Strandveien 55, N-1366 Lysaker
Per Walday, CEO, pw@pcibiotech.no, Mobile: +47 917 93 429
Bernt-Olav Røttingsnes, CFO, bor@pcibiotech.no, Mobile: +47 913 47 021
This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)
[HUG#1375439]
PCI Biotech Investor Presentation: http://hugin.info/139147/R/1375439/337451.pdf
